Gene · 5641
Papers1,807
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,807
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of asparagine endopeptidase inhibitors for treating neurodegenerative diseases. | Trends Mol Med | 2025 | 40000317 | PubTator, text mining | PubMed |
| Intracellular protein ligation and polyprotein synthesis using an asparaginyl endopeptidase core. | Chem Commun (Camb) | 2025 | 39981834 | PubTator, text mining | PubMed |
| Post-translational cleavage generates truncated IgY forms in the snake Elaphe taeniura. | Zool Res | 2025 | 39973137 | PubTator, text mining | PubMed |
| HIF2α drives ccRCC metastasis through transcriptional activation of methylation-controlled J protein and enhanced prolegumain secretion. | Cell Death Dis | 2025 | 39948060 | PubTator, text mining | PubMed |
| Advancements in functional tetrahedral DNA nanostructures for multi-biomarker biosensing: Applications in disease diagnosis, food safety, and environmental monitoring. | Mater Today Bio | 2025 | 39935897 | PubTator, text mining | PubMed |
| Etoposide-induced cancer cell death: roles of mitochondrial VDAC1 and calpain, and resistance mechanisms. | Mol Oncol | 2025 | 39921338 | PubTator, text mining | PubMed |
| Roles of C/EBPβ/AEP in Neurodegenerative Diseases. | Curr Top Med Chem | 2025 | 39871563 | PubTator, text mining | PubMed |
| ApoE3 R136S binds to Tau and blocks its propagation, suppressing neurodegeneration in mice with Alzheimer's disease. | Neuron | 2025 | 39814008 | PubTator, text mining | PubMed |
| Extraction, purification, structural characterization, and biological activity of polysaccharides from Aralia: A review. | Fitoterapia | 2025 | 39778720 | PubTator, text mining | PubMed |
| Asparagine endopeptidase regulates lysosome homeostasis via modulating endomembrane phosphoinositide composition. | Cell Death Dis | 2025 | 39743643 | PubTator, text mining | PubMed |
| The cysteine protease legumain decreases glucose metabolism and enhances fatty acid uptake in human myotubes. | Biochimie | 2025 | 39736316 | PubTator, text mining | PubMed |
| Raman Imaging of Targeted Drug Delivery with DNA-Based Nano-Optical Devices. | Small | 2025 | 39707677 | PubTator, text mining | PubMed |
| Microglia Process α-Synuclein Fibrils and Enhance their Pathogenicity in a TREM2-Dependent Manner. | Adv Sci (Weinh) | 2025 | 39665233 | PubTator, text mining | PubMed |
| Deep phenotyping of T regulatory cells in psoriatic arthritis highlights targetable mechanisms of disease. | J Biol Chem | 2025 | 39662827 | PubTator, text mining | PubMed |
| Predictive Strength of Auditory Maturity Across Different Levels of Language Ability: An Exploratory Quantile Regression Study. | Dev Psychobiol | 2025 | 39648285 | PubTator, text mining | PubMed |
| Natterin-like and legumain insect gut proteins promote the multiplication of a vector-borne bacterial plant pathogen. | Microbiol Res | 2025 | 39616656 | PubTator, text mining | PubMed |
| Legumain deficiency halts atherogenesis by modulating T cell receptor signaling. | Aging Cell | 2025 | 39473192 | PubTator, text mining | PubMed |
| Association Between the Gut Microbiota and Alzheimer's Disease: An Update on Signaling Pathways and Translational Therapeutics. | Mol Neurobiol | 2025 | 39460901 | PubTator, text mining | PubMed |
| A Highly Tumor-Permeating DNA Nanoplatform for Efficient Remodeling of Immunosuppressive Tumor Microenvironments. | Angew Chem Int Ed Engl | 2025 | 39225768 | PubTator, text mining | PubMed |
| Integrated multi-omic high-throughput strategies across-species identified potential key diagnostic, prognostic, and therapeutic targets for atherosclerosis under high glucose conditions. | Mol Cell Biochem | 2025 | 39223351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5641/papers?page=5